Literature DB >> 21209567

Cholinergic dysfunction and cognitive impairment after traumatic brain injury. Part 1: the structure and function of cerebral cholinergic systems.

David B Arciniegas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21209567     DOI： 10.1097/HTR.0b013e31820516cb

Source DB:  PubMed          Journal:  J Head Trauma Rehabil        ISSN： 0885-9701            Impact factor:   2.710


× No keyword cloud information.
  6 in total

1.  Olanzapine Improved Symptoms and Olfactory Function in an Olfactory Reference Syndrome Patient.

Authors:  Alefiya Dhilla Albers; Ilaria Amato; Mark W Albers
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2017-11-14       Impact factor: 2.198

Review 2.  Molecular Imaging of the Cholinergic System in Alzheimer and Lewy Body Dementias: Expanding Views.

Authors:  Prabesh Kanel; Marc-André Bedard; Meghmik Aghourian; Pedro Rosa-Neto; Jean-Paul Soucy; Roger L Albin; Nicolaas I Bohnen
Journal:  Curr Neurol Neurosci Rep       Date:  2021-09-20       Impact factor: 6.030

Review 3.  Addressing neuropsychiatric disturbances during rehabilitation after traumatic brain injury: current and future methods.

Authors:  David B Arciniegas
Journal:  Dialogues Clin Neurosci       Date:  2011       Impact factor: 5.986

Review 4.  Negative neuroplasticity in chronic traumatic brain injury and implications for neurorehabilitation.

Authors:  Jennifer C Tomaszczyk; Nathaniel L Green; Diana Frasca; Brenda Colella; Gary R Turner; Bruce K Christensen; Robin E A Green
Journal:  Neuropsychol Rev       Date:  2014-11-25       Impact factor: 7.444

5.  Treatment With 2-Pentadecyl-2-Oxazoline Restores Mild Traumatic Brain Injury-Induced Sensorial and Neuropsychiatric Dysfunctions.

Authors:  Serena Boccella; Monica Iannotta; Claudia Cristiano; Fabio Arturo Iannotti; Fabio Del Bello; Francesca Guida; Carmela Belardo; Rosmara Infantino; Flavia Ricciardi; Mario Giannella; Antonio Calignano; Vincenzo Di Marzo; Sabatino Maione; Livio Luongo
Journal:  Front Pharmacol       Date:  2020-02-25       Impact factor: 5.810

6.  Positive allosteric modulation of the α7 nicotinic acetylcholine receptor as a treatment for cognitive deficits after traumatic brain injury.

Authors:  David J Titus; Timothy Johnstone; Nathan H Johnson; Sidney H London; Meghana Chapalamadugu; Derk Hogenkamp; Kelvin W Gee; Coleen M Atkins
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.